{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-013426","form_type":"8-K","ticker":"IDXG","cik":"0001054102","company_name":"INTERPACE BIOSCIENCES, INC.","filed_at":"2023-04-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:37.790049+00:00","generated_at":"2026-06-16T15:19:47.775011+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Interpace Biosciences appoints Christopher McCarthy as Principal Financial Officer","bullets":["Christopher McCarthy, 31, appointed Principal Financial Officer effective April 21, 2023.","McCarthy had served as VP of Finance and Enterprise Systems since August 2022.","Prior roles at Interpace: Senior Director of Operations Finance (Aug 2020-Aug 2022) and Senior Financial Analyst (June 2019-Aug 2020).","Before Interpace, he was Senior Financial Systems Analyst at Simon & Schuster (Jan 2016-June 2019).","No family relationships or related party transactions disclosed."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-013426","json":"https://secwatch.observer/filing/0001493152-23-013426.json","markdown":"https://secwatch.observer/filing/0001493152-23-013426.md","text":"https://secwatch.observer/filing/0001493152-23-013426.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1054102/000149315223013426/0001493152-23-013426-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1054102/000149315223013426/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-16T15:19:47.775011+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0e269159a2","claim":"Christopher McCarthy was appointed as Principal Financial Officer at INTERPACE BIOSCIENCES, INC..","evidence_excerpt":"On April 21, 2023, the Board of Directors of Interpace Biosciences, Inc. (the “Company”) appointed Christopher McCarthy, age 31, who has served as the Company’s Vice President of Finance and Enterprise Systems since August 2022, as Principal Financial Officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1054102/000149315223013426/0001493152-23-013426-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Principal Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}